TORNADO-Omics Techniques and Neural Networks for the Development of Predictive Risk Models
Integration of Omics-based Technologies and Artificial Intelligence to Identify Predictive Risk Models in a Air Force's Pilot Cohort for the Maintenance of Safety, Well-being, Health, and Performance to be Translated to Civil Population
1 other identifier
observational
200
1 country
1
Brief Summary
The goal of this observational study is to define a personalized risk model in the super healthy and homogeneous population of Italian Air Force high-performance pilots. This peculiar cohort conducts dynamic activities in an extreme environment, compared to a population of military people not involved in flight activity. The study integrates the analyses of biological samples (urine, blood, and saliva), clinical records, and occupational data collected at different time points and analyzed by omic-based approaches supported by Artificial Intelligence. Data resulting from the study will clarify many etiopathological mechanisms of diseases, allowing the creation of a model of analyses that can be extended to the civilian population and patient cohorts for the potentiation of precision and preventive medicine.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2024
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 5, 2024
CompletedFirst Submitted
Initial submission to the registry
March 21, 2024
CompletedFirst Posted
Study publicly available on registry
April 17, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 5, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 5, 2027
ExpectedApril 17, 2024
March 1, 2024
1 year
March 21, 2024
April 16, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessment of flight-related exposure data and molecular modifications
Collection of information on: i) lifestyle, ii) medical examination, iii) previous trauma, iv) cumulative professional exposure to flying, determination of panel of genes and circulating markers to assess prognostic and predictive factors
Through study completion, an average of 3 year
Secondary Outcomes (4)
Assessment of General Health
Through study completion, an average of 3 year
Assessment of Sleep Quality
Through study completion, an average of 3 year
Assessment of eating habits
Through study completion, an average of 3 year
Creation of reliable AI and disease-based models for personalized medicine
Through study completion, an average of 3 year
Study Arms (2)
High-performance Italian Air Force Pilots
The primary study cohort is represented by "super-healthy" high-performance Italian Air Force Pilots, aged between 26 and 38 years, in active flight service. Intervention: not applicable
Italian Air Force ground staff
This cohort of Italian Air Force ground personnel will be used as a control group to compare data from the pilot cohort.
Interventions
Collection of biological samples (blood, urine, saliva) and clinical data
Eligibility Criteria
The study population will consist of high-performance Italian Air Force pilots, compared to Italian Air Force ground staff.
You may qualify if:
- Being part of the Italian Air Force, as in active flight service or ground staff
- Age between 26 and 38 years
- Consent to collect biological samples and use the wearable device to monitor exposure parameters
You may not qualify if:
- Age \< 25 years and \> 39 years
- no signature on informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinicolead
- University of Milancollaborator
- Italian Air Forcecollaborator
- A-Tonocollaborator
- Ministry of Defense, Italycollaborator
Study Sites (1)
CeMATA - Joint Center for Aerospace Medicine and Advanced Therapy
Milan, 20139, Italy
Related Publications (2)
Marfia G, Navone SE, Guarnaccia L, Campanella R, Locatelli M, Miozzo M, Perelli P, Della Morte G, Catamo L, Tondo P, Campanella C, Lucertini M, Ciniglio Appiani G, Landolfi A, Garzia E. Space flight and central nervous system: Friends or enemies? Challenges and opportunities for neuroscience and neuro-oncology. J Neurosci Res. 2022 Sep;100(9):1649-1663. doi: 10.1002/jnr.25066. Epub 2022 Jun 9.
PMID: 35678198RESULTMarfia G, Guarnaccia L, Navone SE, Ampollini A, Balsamo M, Benelli F, Gaudino C, Garzia E, Fratocchi C, Di Murro C, Ligarotti GK, Campanella C, Landolfi A, Perelli P, Locatelli M, Ciniglio Appiani G. Microgravity and the intervertebral disc: The impact of space conditions on the biomechanics of the spine. Front Physiol. 2023 Mar 14;14:1124991. doi: 10.3389/fphys.2023.1124991. eCollection 2023.
PMID: 36998982RESULT
Biospecimen
Blood, urine, salivae
Study Officials
- PRINCIPAL INVESTIGATOR
Giovanni Marfia, MD, PhD
Fondazione IRCCs Ca' Granda Ospedale MAggiore Policlinico, Italian Air Force
- STUDY CHAIR
Emanuele Garzia, MD, PhD
Italian Air Force
- STUDY CHAIR
Marco Locatelli, MD, PhD
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- STUDY CHAIR
Francesco Vestito, PhD
Italian Air Force
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 21, 2024
First Posted
April 17, 2024
Study Start
February 5, 2024
Primary Completion
February 5, 2025
Study Completion (Estimated)
February 5, 2027
Last Updated
April 17, 2024
Record last verified: 2024-03
Data Sharing
- IPD Sharing
- Will not share
Subject's data will be collected in completely anonymized form.